Ambroxol for neuropathic pain: hiding in plain sight?
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Ambroxol is a multifaceted drug with primarily mucoactive and secretolytic actions, along with anti-inflammatory, antioxidant, and local anaesthetic properties. It has a long history of use in the treatment of respiratory tract diseases and has shown to be efficacious in relieving sore throat. In more recent years, ambroxol has gained interest for its potential usefulness in treating neuropathic pain. Research into this area has been slow, despite clear preclinical evidence to support its primary analgesic mechanism of action—blockade of voltage-gated sodium (Na v) channels in sensory neurons. Ambroxol is a commercially available inhibitor of Na v 1.8, a crucial player in the pathophysiology of neuropathic pain, and Na v 1.7, a particularly exciting target for the treatment of chronic pain. In this review, we discuss the analgesic mechanisms of action of ambroxol, as well as proposed synergistic properties, followed by the preclinical and clinical results of its use in the treatment of persistent pain and neuropathic pain symptoms, including trigeminal neuralgia, fibromyalgia, and complex regional pain syndrome. With its well-established safety profile, extensive preclinical and clinical drug data, and early evidence of clinical effectiveness, ambroxol is an old drug worthy of further investigation for repurposing. As a patent-expired drug, a push is needed to progress the drug to clinical trials for neuropathic pain. We encourage the pharmaceutical industry to look at patented drug formulations and take an active role in bringing an optimized version for neuropathic pain to market.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is extensive evidence supporting the use of ambroxol to treat neuropathic pain secondary to trigeminal neuralgia, fibromyalgia, and complex regional pain syndrome 25.”
From Clinical phenotype and management of sound-induced pain: Insights from adults with pain hyperacusis (2025) · cites this paper as [25]
Citations
Cites
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Self-citationChronic pain: an update on burden, best practices, and new advances
Cohen, S. P., Vase, L., & Hooten, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00393-7 · Cited by 2,614
Neuropathic pain in the general population: A systematic review of epidemiological studies
van Hecke, O., Austin, S. K., Khan, R. A., Smith, B. H., & Torrance, N. (2014) · Pain · doi:10.1016/j.pain.2013.11.013 · Cited by 1,602
An SCN9A channelopathy causes congenital inability to experience pain
Cox, J. J., Reimann, F., Nicholas, A. K., Thornton, G., Roberts, E., Springell, K., Karbani, G., Jafri, H., Mannan, J., Raashid, Y., et al. (2006) · Nature · doi:10.1038/nature05413 · Cited by 1,600
International association for the study of pain
Cousins, M. (1989) · Pain · doi:10.1016/0304-3959(89)90017-1 · Cited by 1,202
The Role of Voltage-Gated Sodium Channels in Pain Signaling
Bennett, D. L., Clark, A. J., Huang, J., Waxman, S. G., & Dib-Hajj, S. D. (2019) · Physiological Reviews · doi:10.1152/physrev.00052.2017 · Cited by 730
Neuroinflammation and the generation of neuropathic pain
Ellis, A., & Bennett, D. L. H. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet128 · Cited by 615
Contribution of Nav1.8 Sodium Channels to Action Potential Electrogenesis in DRG Neurons
Renganathan, M., Cummins, T. R., & Waxman, S. G. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.2.629 · Cited by 566
Gabapentin for chronic neuropathic pain in adults
Wiffen, P. J., Derry, S., Bell, R. F., Rice, A. S., Tölle, T. R., Phillips, T., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub4 · Cited by 561
Gain of function Na V 1.7 mutations in idiopathic small fiber neuropathy
Faber, C. G., Hoeijmakers, J. G. J., Ahn, H., Cheng, X., Han, C., Choi, J., Estacion, M., Lauria, G., Vanhoutte, E. K., Gerrits, M. M., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22485 · Cited by 557
Research works printed but not linked: 4
- Fischer, 2002, Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat. Randomised, double-blind, placebo-controlled trials regarding the local anaesthetic properties, Arzneimittelforschung, 52, 256
- Klier, 1977, The local anesthetic effect of NA872-containing eyedrops [in German], Med Monatsschr, 31, 575
- Renovanz, 1975, Results of some clinical-pharmacological studies on ambroxol (NA 872) [in German], Arzneimittelforschung, 25, 646
- Schutz, 2002, Local anaesthetic properties of ambroxol hydrochloride lozenges in view of sore throat. Clinical proof of concept, Arzneimittelforschung, 52, 194
Cited by
Advances and challenges in neuropathic pain: a narrative review and future directions
Attal, N., Bouhassira, D., & Colvin, L. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.04.021 · Cited by 171
Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain
Bernatonienė, J., Ščiupokas, A., Kopustinskienė, D. M., & Petrikonis, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071799 · Cited by 47
The Antinociceptive Role of Nrf2 in Neuropathic Pain: From Mechanisms to Clinical Perspectives
Petrikonis, K., Bernatonienė, J., Kopustinskienė, D. M., Casale, R., Davinelli, S., & Saso, L. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081068 · Cited by 39
Leoni, M. L. G., Mercieri, M., Viswanath, O., Cascella, M., Rekatsina, M., Pasqualucci, A., Caruso, A., & Varrassi, G. (2025) · Current Pain and Headache Reports · doi:10.1007/s11916-025-01384-1 · Cited by 33
Tang, J., Chen, Q., Xiang, L., Tu, T., Zhang, Y., & Ou, C. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04133-4 · Cited by 26
Metadata
- Authors
- Russo, M. A., Baron, R., Dickenson, A. H., Kern, K.-U., & Santarelli, D. M.
- Affiliations
- Hunter Pain Specialists, Broadmeadow, NSW, Australia
- University Hospital Schleswig-Holstein (DE)
- University College London (GB)
- Institute for Pain Medicine/Pain Practice Wiesbaden, Wiesbaden, Germany
- Genesis Research Services, Broadmeadow, NSW, Australia
- Corresponding author
- Russo, Marc A.
- Venue
- Pain
- Published
- 2022-05-17
- Volume
- 164
- Issue
- 1
- Pages
- 3-13
- ISSN
- 0304-3959 (ISSN-L)
- 1872-6623
- OpenAlex
- W4280593627
- Semantic Scholar
- ff17d21f09702a48998a3d64e4595fd71a854e5e
- Cited by
- 20
- References
- 83
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 6 · 2023: 2
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pain (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- ambroxol, neuropathic pain, voltage-gated sodium channels, Nav1.8, Nav1.7, analgesic mechanism, drug repurposing, trigeminal neuralgia, fibromyalgia, complex regional pain syndrome, chronic pain, sensory neurons, mucoactive agents
- MeSH terms
- Ambroxol, Analgesics, Anesthetics, Local, Humans, Neuralgia, Pain Measurement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ambroxol for neuropathic pain: hiding in plain sight? https://app.cochat.ai/papers/10.1097/j.pain.0000000000002693
- The paper
- Russo, M. A., Baron, R., Dickenson, A. H., Kern, K.-U., & Santarelli, D. M. (2023). Ambroxol for neuropathic pain: hiding in plain sight? Pain. https://doi.org/10.1097/j.pain.0000000000002693
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.